These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6296186)

  • 41. Aldosterone receptors in different types of primary hyperaldosteronism.
    Armanini D; Witzgall H; Wehling M; Kuhnle U; Weber PC
    J Clin Endocrinol Metab; 1987 Jul; 65(1):101-4. PubMed ID: 3034947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptor binding and biological activity of 18-hydroxycortisol.
    Gomez-Sanchez EP; Gomez-Sanchez CE; Smith JS; Ferris MW; Foecking M
    Endocrinology; 1984 Aug; 115(2):462-6. PubMed ID: 6086271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism.
    Gross MD; Grekin RJ; Gniadek TC; Villareal JZ
    N Engl J Med; 1981 Jul; 305(4):181-5. PubMed ID: 7017408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extinction of mineralocorticoid effects in 19-norprogesterone derivatives: structure-activity relationships.
    Paris J; Botella J; Fournau P; Bonnet P; Thevenot R
    J Pharmacol Exp Ther; 1987 Oct; 243(1):288-91. PubMed ID: 2822901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression of type I adrenal steroid receptors in immune tissues is associated with tissue-specific regulation of type II receptors by aldosterone.
    Miller AH; Spencer RL; Husain A; Rhee R; McEwen BS; Stein M
    Endocrinology; 1993 Nov; 133(5):2133-40. PubMed ID: 8404663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
    Spencer RL; Kim PJ; Kalman BA; Cole MA
    Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mineralocorticoid receptors in the rat lung.
    Krozowski Z; Funder JW
    Endocrinology; 1981 Dec; 109(6):1811-3. PubMed ID: 6273117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mineralocorticoid activity of 21-deoxyaldosterone derivatives: structure-function studies.
    Wynne KN; Rae ID; O'Keefe DF; Adam WR; Pearce P; Stockigt JR; Funder JW
    J Steroid Biochem; 1981 Oct; 14(10):1041-4. PubMed ID: 6272022
    [No Abstract]   [Full Text] [Related]  

  • 49. Mineralocorticoid receptor-like aldosterone-binding protein in cell culture.
    Lan NC; Matulich DT; Morris JA; Baxter JD
    Endocrinology; 1981 Dec; 109(6):1963-70. PubMed ID: 6273124
    [No Abstract]   [Full Text] [Related]  

  • 50. 18-oxocortisol, a naturally occurring mineralocorticoid agonist.
    Ulick S; Land M; Chu MD
    Endocrinology; 1983 Dec; 113(6):2320-2. PubMed ID: 6641637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
    Yamakawa M; Ezumi K; Shiro M; Nakai H; Kamata S; Matsui T; Haga N
    Mol Pharmacol; 1986 Dec; 30(6):585-9. PubMed ID: 3023811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Casals-Stenzel J; Buse M; Wambach G; Losert W
    Arzneimittelforschung; 1984; 34(3):241-6. PubMed ID: 6329237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of development and adrenal steroids in the regulation of the mineralocorticoid receptor messenger RNA.
    Kalinyak JE; Bradshaw JG; Perlman AJ
    Horm Metab Res; 1992 Mar; 24(3):106-9. PubMed ID: 1315713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies.
    Funder J; Myles K
    Endocrinology; 1996 Dec; 137(12):5264-8. PubMed ID: 8940344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Determination and action mechanism of mineralocorticoids].
    Kumagai A; Nishikawa T
    Nihon Rinsho; 1981 Sep; 39(9):2993-8. PubMed ID: 6279930
    [No Abstract]   [Full Text] [Related]  

  • 56. SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate.
    Cutler GB; Pita JC; Rifka SM; Menard RH; Sauer MA; Loriaux DL
    J Clin Endocrinol Metab; 1978 Jul; 47(1):171-5. PubMed ID: 263288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?
    Chai W; Hofland J; Jansen PM; Garrelds IM; de Vries R; van den Bogaerdt AJ; Feelders RA; de Jong FH; Danser AH
    J Hypertens; 2010 May; 28(5):1044-53. PubMed ID: 20179635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of FKBP51 by aldosterone in intestinal epithelium.
    Petrovich E; Asher C; Garty H
    J Steroid Biochem Mol Biol; 2014 Jan; 139():78-87. PubMed ID: 24139875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on arterial mineralocorticoid and glucocorticoid receptors: evidence for the translocation of steroid-cytoplasmic receptor complexes to cell nuclei.
    Kornel L; Kanamarlapudi N; Ramsay C; Taff DJ
    Clin Physiol Biochem; 1984; 2(1):14-31. PubMed ID: 6091978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo nuclear translocation of mineralocorticoid and glucocorticoid receptors in rat kidney: differential effect of corticosteroids along the distal tubule.
    Ackermann D; Gresko N; Carrel M; Loffing-Cueni D; Habermehl D; Gomez-Sanchez C; Rossier BC; Loffing J
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1473-85. PubMed ID: 20861076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.